By-health Co., Ltd. Class A

By-health Co., Ltd. Class A

SSZSE:300146
10.17
CNY
+0.02
(+0.20%)
0.42EPS
22.97P/E
15.95BMarket Cap
Mar 22Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.12
1.31
1.57
1.6
2.11
3
3.55
3.84
4.49
4.65
5.55
4.09
3.76
3.97
Basic EPS, GAAP
0.32
0.38
0.44
0.37
0.52
0.69
-0.24
0.96
1.06
0.82
1.03
0.39
0.47
0.41
Free Cash Flow per Basic Share
0.35
0.28
0.25
0.37
0.54
0.76
0.81
0.78
0.94
0.67
0.47
0.23
0.65
- -
Dividend per Share
0.1
0.25
0.25
0.31
0.26
0.35
0.53
0.37
0.67
0.7
0.18
0.91
0.36
0.45
Book Value per Share
1.7
1.86
3.13
3.18
3.47
3.86
3.79
4.42
6.17
6.29
7.15
6.5
6.57
6.55
Tangible Book Value per Share
1.63
1.78
3.02
3.03
3.32
1.3
2.47
3.05
5.03
5.17
6.05
5.52
5.61
5.63
Basic Weighted Avg Shares
1,318
1,305
1,444
1,447
1,474
1,452
1,483
1,588
1,655
1,690
1,695
1,674
1,664
1,675
Sales/Revenue/Turnover
1,482
1,705
2,266
2,309
3,111
4,351
5,262
6,095
7,431
7,861
9,407
6,838
6,265
6,648
Operating Margin (%)
31.69
31.04
28.34
24.5
24.77
25.8
23.32
22.46
24.66
20.18
20
11.64
14.74
12.52
Depreciation Expense
37
44
60
81
98
147
249
205
246
244
248
262
290
- -
Net Income, GAAP
422
503
635
535
766
1,002
-356
1,524
1,754
1,386
1,746
653
782
688
Effective Tax Rate (%)
16.2
15.14
16.17
22.34
13.36
19.54
- -
12.7
18.9
17.22
19
28.06
19.03
20.34
Profit Margin (%)
28.45
29.48
28.04
23.18
24.63
23.03
-6.76
25.01
23.6
17.63
18.56
9.55
12.48
10.34
Working Capital
1,644
1,669
2,800
2,623
3,146
2,604
2,051
2,587
5,268
5,182
5,850
4,627
5,030
5,155
LT Debt
- -
- -
- -
- -
- -
893
308
179
41
4
161
- -
84
85
Total Equity
2,233
2,448
4,554
4,704
5,132
6,971
5,931
6,991
10,537
10,756
12,242
11,097
11,190
11,152
Return on Invested Capital (%)
20
19.82
17.12
10.59
15.36
13.35
- -
22.41
18.25
12.39
14.35
4.7
6.32
5.62
Return on Capital (%)
18.89
19.89
17.36
12.28
15.57
16.88
- -
22.12
19.55
12.74
14.81
5.32
6.11
5.6
Return on Common Equity (%)
20.27
21.48
18.13
11.58
15.67
18.6
-6.1
23.5
20.07
13.08
15.28
5.62
7.06
6.17

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
900
997
1,099
LT Borrowings
84
84
84
LT Finance Leases
- -
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,692
1,692
1,692
Market Capitalization
18,575
15,293
15,953

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
7,683
7,559
7,518
Cash, Cash Equivalents & STI
5,925
5,390
5,282
Accounts Receivable, Net
505
499
546
Inventories
644
736
739
Total Current Liabilities
2,275
2,317
2,363
Payables & Accruals
- -
- -
- -
ST Debt
900
997
1,099
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.93%
11.62%
0.84%
Free Cash Flow
24.62%
19.99%
184.15%
Net Income, GAAP
-62.83%
-4.54%
19.81%
Sales/Revenue/Turnover
12.49%
2.34%
-8.38%
Total Cash Common Dividend
42.7%
71.12%
-59.98%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,646
1,967
1,120
1,105
6,838
2025
1,792
1,741
- -
1,350
6,265
2026
1,869
1,803
1,626
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.43
0.1
-0.01
-0.13
0.39
2025
0.27
0.17
- -
-0.07
0.47
2026
0.24
0.12
0.13
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.91
2025
- -
- -
- -
- -
0.36
2026
- -
0.45
- -
- -
- -

Company Description

CEO
Zhi Cheng Lin
Full Time Employees
3,049
Sector
Health technology
Industry
Pharmaceuticals: other
Address
No. 916, Huangpu Avenue East Guangzhou GD China 510700
IPO Date
Dec 14, 2010
Business
By-Health Co., Ltd. (300146.SZ) is a leading China-based manufacturer and distributor of nutritional health products, focusing on dietary supplements, functional foods, and wellness solutions for consumer markets. The company offers a comprehensive portfolio of products including vitamin and mineral supplements under the By-health brand; probiotics and digestive health formulas; protein powders and meal replacements; traditional Chinese medicine-inspired herbal extracts; and specialized lines for immunity, beauty, sleep, and joint health, distributed through e-commerce platforms, retail chains, and direct sales channels primarily in China with expanding operations in Southeast Asia and North America. Founded in 1995 and headquartered in Shenzhen, China, By-Health operates in the health and wellness industry, targeting middle-class consumers, families, and aging populations with science-backed formulations emphasizing quality control and R&D innovation through its in-house laboratories and partnerships with global ingredient suppliers. In recent developments, the company completed a strategic acquisition of a key probiotic technology firm in 2024 to bolster its gut health segment, launched a new line of personalized nutrition products via AI-driven apps in early 2025, and formed alliances with international e-commerce giants for overseas expansion amid rising global demand for Chinese health brands.